JP2003505513A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003505513A5 JP2003505513A5 JP2001513423A JP2001513423A JP2003505513A5 JP 2003505513 A5 JP2003505513 A5 JP 2003505513A5 JP 2001513423 A JP2001513423 A JP 2001513423A JP 2001513423 A JP2001513423 A JP 2001513423A JP 2003505513 A5 JP2003505513 A5 JP 2003505513A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- composition according
- platinum coordination
- coordination complex
- cisplatin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 description 10
- 229910052697 platinum Inorganic materials 0.000 description 7
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 7
- -1 platinum coordination complex Chemical class 0.000 description 7
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 5
- 229960004316 cisplatin Drugs 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 230000000259 anti-tumor effect Effects 0.000 description 4
- VSRXQHXAPYXROS-UHFFFAOYSA-N azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+) Chemical compound [NH2-].[NH2-].[Pt+2].OC(=O)C1(C(O)=O)CCC1 VSRXQHXAPYXROS-UHFFFAOYSA-N 0.000 description 3
- 229960004562 carboplatin Drugs 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- 229950010897 iproplatin Drugs 0.000 description 3
- 230000001613 neoplastic effect Effects 0.000 description 3
- 229960001756 oxaliplatin Drugs 0.000 description 3
- DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical compound O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 description 3
- 230000002062 proliferating effect Effects 0.000 description 3
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 description 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 125000001072 heteroaryl group Chemical group 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14643699P | 1999-07-29 | 1999-07-29 | |
| US60/146,436 | 1999-07-29 | ||
| PCT/US2000/020763 WO2001008693A2 (en) | 1999-07-29 | 2000-07-27 | Combination therapy using pentafluorobenzenesulfonamide and platin compound |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003505513A JP2003505513A (ja) | 2003-02-12 |
| JP2003505513A5 true JP2003505513A5 (https=) | 2007-09-06 |
Family
ID=22517356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001513423A Pending JP2003505513A (ja) | 1999-07-29 | 2000-07-27 | ペンタフルオロベンゼンスルホンアミドを用いる併用療法 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6355628B1 (https=) |
| EP (1) | EP1206256B8 (https=) |
| JP (1) | JP2003505513A (https=) |
| KR (1) | KR100685059B1 (https=) |
| CN (1) | CN1181819C (https=) |
| AT (1) | ATE294574T1 (https=) |
| AU (1) | AU775305B2 (https=) |
| CA (1) | CA2380078C (https=) |
| DE (1) | DE60019937T2 (https=) |
| DK (1) | DK1206256T3 (https=) |
| ES (1) | ES2241639T3 (https=) |
| IL (2) | IL147890A0 (https=) |
| PT (1) | PT1206256E (https=) |
| RU (1) | RU2268054C2 (https=) |
| WO (1) | WO2001008693A2 (https=) |
| ZA (1) | ZA200200889B (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT896533E (pt) * | 1996-02-22 | 2004-02-27 | Tularik Inc | Pentafluorobenzenosulfonamidas e analogos |
| PT939627E (pt) * | 1996-07-19 | 2004-02-27 | Tularik Inc | Pentafluorobenzenossulfonamidas e analogos |
| DE69908156T2 (de) * | 1998-09-23 | 2003-12-24 | Tularik, Inc. | Arylsulfonanilid-harnstoffe |
| WO2002039958A2 (en) | 2000-11-03 | 2002-05-23 | Tularik Inc. | Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents |
| US20050250854A1 (en) * | 2000-11-03 | 2005-11-10 | Amgen Inc. | Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents |
| FR2834641B1 (fr) * | 2002-01-14 | 2005-04-22 | Ct Regional De Lutte Contre Le | Protection de la neurotoxicite de l'oxaliplatine par administration de calcium et de magnesium |
| WO2005051303A2 (en) * | 2003-11-19 | 2005-06-09 | Lixin Zhang | Screening for synergistic compounds |
| US10238831B2 (en) | 2013-09-08 | 2019-03-26 | Qool Therapeutics, Inc. | Temperature measurement and feedback for therapeutic hypothermia |
| EP3261593B1 (en) | 2015-02-23 | 2021-11-03 | Qool Therapeutics, Inc. | Systems and methods for endotracheal delivery of frozen particles |
| US11186549B2 (en) | 2017-08-29 | 2021-11-30 | Rutgers, The State University Of New Jersey | Therapeutic indazoles |
| CA3113532A1 (en) * | 2017-09-21 | 2019-03-28 | Dalriada Therapeutics Inc. | Pentafluorophenyl sulfonamide compounds, compositions and uses thereof |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1955207A (en) | 1931-09-16 | 1934-04-17 | Ig Farbenindustrie Ag | Mothproofing agent |
| US2402623A (en) | 1943-06-24 | 1946-06-25 | Rohm & Haas | Nu-nitroaryl haloarylsulphonamides |
| CH362688A (de) | 1957-09-10 | 1962-06-30 | Geigy Ag J R | Verfahren zur Herstellung von neuen Arylsulfonarylamiden |
| GB1242057A (en) | 1968-07-04 | 1971-08-11 | Ici Ltd | Derivatives of 4-hydroxytetrafluoropyridine and the use thereof as plant growth regulators |
| NL174644C (nl) | 1970-04-13 | 1984-07-16 | Minnesota Mining & Mfg | Werkwijze ter bereiding van een herbicide verbinding; tevens werkwijze voor de bereiding van een preparaat met herbicide werking. |
| US4225529A (en) * | 1977-10-19 | 1980-09-30 | Johnson, Matthey & Co., Limited | Compositions containing platinum |
| DE3623184A1 (de) | 1986-07-10 | 1988-01-14 | Kali Chemie Ag | Verfahren zur herstellung von n-fluorsulfonamiden |
| US4883914A (en) | 1987-08-17 | 1989-11-28 | American Cyanamid Company | Benzenesulfonyl carboxamide compounds useful as herbicidal agents |
| DE3804990A1 (de) | 1988-02-18 | 1989-08-31 | Basf Ag | Herbizid wirksame, heterocyclisch substituierte sulfonamide |
| FR2645537B1 (fr) | 1989-04-05 | 1994-03-04 | Fabre Medicament Pierre | Nouveaux sulfonamides derives d'acides benzocycliques ou benzoheterocycliques, leur preparation et leur application en therapeutique |
| FR2665440B1 (fr) | 1990-07-31 | 1994-02-04 | Lipha | Nouveaux cycloalkylsulfonamides substitues, procedes de preparation et medicaments les contenant. |
| US5189211A (en) | 1990-08-01 | 1993-02-23 | Taisho Pharmaceutical Co., Ltd. | Sulfonamide derivatives |
| DE69129611T2 (de) | 1990-08-20 | 1998-12-17 | Eisai Co., Ltd., Tokio/Tokyo | Sulfonamid-Derivate |
| RU2088288C1 (ru) * | 1993-07-29 | 1997-08-27 | Московский областной научно-исследовательский клинический институт | Способ лечения больных местнораспространенными формами рака |
| RU2098096C1 (ru) * | 1993-10-11 | 1997-12-10 | Московский научно-исследовательский онкологический институт им.П.А.Герцена | Средства, подавляющие рост раковых клеток |
| WO1996040629A1 (en) | 1995-06-07 | 1996-12-19 | Sugen, Inc. | Tyrphostin-like compounds for the treatment of cell proliferative disorders or cell differentiation disorders |
| PT896533E (pt) | 1996-02-22 | 2004-02-27 | Tularik Inc | Pentafluorobenzenosulfonamidas e analogos |
| PT939627E (pt) * | 1996-07-19 | 2004-02-27 | Tularik Inc | Pentafluorobenzenossulfonamidas e analogos |
| DE69729946T2 (de) * | 1996-10-15 | 2005-01-20 | G.D. Searle Llc | Verwendung von cyclooxygenase-2 inhibitoren zur behandlung und verbeugung von neoplasia |
| BR9713522A (pt) * | 1996-11-19 | 2000-03-21 | Searle & Co | Método de uso de inibidores da cicloxigenase-2 como agentes antiangiogênicos. |
| US5773236A (en) | 1997-04-25 | 1998-06-30 | Molecule Probes, Inc. | Assay for glutathiane transferase using polyhaloaryl-substituted reporter molecules |
| WO1999067258A1 (en) * | 1998-06-25 | 1999-12-29 | Tularik Inc. | Arylsulfonanilide phosphates |
| DE69908156T2 (de) * | 1998-09-23 | 2003-12-24 | Tularik, Inc. | Arylsulfonanilid-harnstoffe |
| AU2190700A (en) * | 1998-12-17 | 2000-07-03 | Tularik Inc. | Tubulin-binding agents |
| CO5170498A1 (es) * | 1999-05-28 | 2002-06-27 | Abbott Lab | Biaril sulfonamidas son utiles como inhibidores de proliferacion celular |
-
2000
- 2000-07-27 RU RU2002105374/15A patent/RU2268054C2/ru not_active IP Right Cessation
- 2000-07-27 DE DE60019937T patent/DE60019937T2/de not_active Expired - Fee Related
- 2000-07-27 US US09/627,041 patent/US6355628B1/en not_active Expired - Fee Related
- 2000-07-27 AU AU66152/00A patent/AU775305B2/en not_active Ceased
- 2000-07-27 KR KR1020027001254A patent/KR100685059B1/ko not_active Expired - Fee Related
- 2000-07-27 PT PT00953755T patent/PT1206256E/pt unknown
- 2000-07-27 CA CA002380078A patent/CA2380078C/en not_active Expired - Fee Related
- 2000-07-27 JP JP2001513423A patent/JP2003505513A/ja active Pending
- 2000-07-27 CN CNB00810977XA patent/CN1181819C/zh not_active Expired - Fee Related
- 2000-07-27 DK DK00953755T patent/DK1206256T3/da active
- 2000-07-27 IL IL14789000A patent/IL147890A0/xx active IP Right Grant
- 2000-07-27 WO PCT/US2000/020763 patent/WO2001008693A2/en not_active Ceased
- 2000-07-27 AT AT00953755T patent/ATE294574T1/de not_active IP Right Cessation
- 2000-07-27 ES ES00953755T patent/ES2241639T3/es not_active Expired - Lifetime
- 2000-07-27 EP EP00953755A patent/EP1206256B8/en not_active Expired - Lifetime
-
2002
- 2002-01-29 IL IL147890A patent/IL147890A/en not_active IP Right Cessation
- 2002-01-31 ZA ZA200200889A patent/ZA200200889B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003505513A5 (https=) | ||
| JP2005521713A5 (https=) | ||
| JP2007511504A5 (https=) | ||
| JP2005539088A5 (https=) | ||
| JP2006523216A5 (https=) | ||
| JP2009519249A5 (https=) | ||
| WO2012144463A1 (ja) | 腫瘍治療剤 | |
| JP2010530372A5 (https=) | ||
| JP2004525079A5 (https=) | ||
| JP2003520195A5 (https=) | ||
| JP2002030084A5 (https=) | ||
| JP2005511699A5 (https=) | ||
| JP2003522198A5 (https=) | ||
| JP2004502732A5 (https=) | ||
| JP2761297B2 (ja) | 抗腫瘍活性を有する三核カチオン性プラチナ錯体、及びこれを含有する医薬組成物 | |
| JP2006525368A5 (https=) | ||
| RU2002105374A (ru) | Сочетанная терапия с использованием пентафторбензолсульфонамидов | |
| RU2004105144A (ru) | Комбинации, включающие эпотилоны, и их фармацевтическое применение | |
| JP2002510667A5 (https=) | ||
| JP2019513812A5 (https=) | ||
| RU2004117595A (ru) | Производные пиридина в качестве лигандов рецептора nmda | |
| CA2373634A1 (en) | Isophosphoramide mustard analogs and use thereof | |
| JP2018536716A5 (https=) | ||
| JP2006510659A5 (https=) | ||
| JP2006508124A5 (https=) |